Artwork

Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

JAMA: 2011-01-12, Vol. 305, No. 2, Author in the Room™ Audio Interview

54:22
 
Share
 

Manage episode 337237125 series 3380326
Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Interview with Steven J. Jacobsen, MD, PhD, author of Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease. Summary Points: 1. The findings suggest that the zoster vaccine is as effective in a community setting with its mixed population and routine clinical practices as was found in the controlled clinical trials. 2. To date, the uptake of the zoster vaccine has been modest due to a number of reasons, including weaknesses in the adult vaccine infrastructure, knowledge and beliefs of clinicians and patients, periodic supply shortfalls, as well as financial reasons. 3. Because zoster and its attendant neurologic complication of postherpetic neuralgia are common and serious among the elderly, it seems prudent to recommend zoster vaccine. The potential impact of vaccination on the burden of the disease in this population is significant.
  continue reading

97 episodes

Artwork
iconShare
 
Manage episode 337237125 series 3380326
Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Interview with Steven J. Jacobsen, MD, PhD, author of Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease. Summary Points: 1. The findings suggest that the zoster vaccine is as effective in a community setting with its mixed population and routine clinical practices as was found in the controlled clinical trials. 2. To date, the uptake of the zoster vaccine has been modest due to a number of reasons, including weaknesses in the adult vaccine infrastructure, knowledge and beliefs of clinicians and patients, periodic supply shortfalls, as well as financial reasons. 3. Because zoster and its attendant neurologic complication of postherpetic neuralgia are common and serious among the elderly, it seems prudent to recommend zoster vaccine. The potential impact of vaccination on the burden of the disease in this population is significant.
  continue reading

97 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide